Oxidative stress in viral and alcoholic hepatitis

Free Radical Biology and Medicine

Volumn 34, Issue 1, 2003, Pages 1-10

  Loguercio, Carmela ^a,b   Federico, Alessandro ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Alcohol; Antioxidants; Free radicals; Liver disease; Viral hepatitis

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; ACETYLCYSTEINE; ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CASPASE INHIBITOR; CYTOCHROME P450; CYTOKINE; ENDOTOXIN; GLUTATHIONE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MALONALDEHYDE; PEROXYNITRITE; PLANT EXTRACT; PSYLLANTUS AMARUM EXTRACT; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RIBAVIRIN; S ADENOSYLMETHIONINE; SALVIA MILTIORRHIZA EXTRACT; SELENIUM; SYLIBUM MARIANUM EXTRACT; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VIRUS VECTOR;

ACUTE HEPATITIS; ALCOHOL LIVER DISEASE; APOPTOSIS; BLOOD LEVEL; DISEASE COURSE; DISEASE MARKER; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; HEPATITIS C VIRUS; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KUPFFER CELL; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER INJURY; LIVER ISCHEMIA; LIVER NECROSIS; LIVER REGENERATION; MACROPHAGE ACTIVATION; MITOCHONDRION; MONITORING; NEUTROPHIL; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; STELLATE CELL; TRANSCRIPTION INITIATION; TRANSGENE; TREATMENT PLANNING; VIRUS HEPATITIS; VIRUS INFECTION;

EID: 0037218573     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01167-X     Document Type: Article

References (139)

1. Jones B.E., Czaja M.J. Mechanisms of hepatic toxicity III. Intracellular signaling in response to toxic liver injury. Am J Physiol. 275:1998;874-878.
2. Kaplowitz N. Mechanisms of liver cell injury. J Hepatol. 32:2000;39-47.
3. Jakus V., Lopuchova M. Role of free radicals, oxidative stress and antioxidant systems in liver diseases. Bratisl. Lek. Listy. 100:1999;548-559.
4. Par A., Roth E., Rumi G., Kovacs Z., Nemes J., Mozsik G. Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C. Orv Hetil. 141:2000;1559-1655.
5. Mori N., Hirayama K. Long-term consumption of a methionine-supplemented diet increases iron and lipid peroxide levels in rat liver. J Nutr. 130:2000;2349-2355.
6. Peterhans E. Reactive oxygen species and nitric oxide in viral diseases. Biol Trace Elem Res. 56:1997;107-116.
7. Loguercio C., Nardone G., Sicolo P., Cuomo R., Del Vecchio Blanco C., Budillon G. Intravenous load of fructose and fructose 1,6-diphosphate effect on uricemia in patients with non-alcoholic liver disease. Am J Gastroenterol. 91:1996;559-564.
8. + permeability, and cell volume in rat hepatoma cells. Gastroenterology. 118:2000;395-403.
9. Paradis V., Kollinger M., Fabre M., Holstege A., Poynard T., Bedossa P. In situ detection of lipid peroxidation by products in chronic liver diseases. Hepatology. 26:1997;135-142.
10. Yamamoto Y., Yamashita S., Fujisawa A., Kokura S., Yoshikawa T. Oxidative stress in patients with hepatitis, cirrhosis, and hepatoma evaluated by plasma antioxidants. Biochem Biophys Res Commun. 247:1998;166-170.
11. Ohhira M., Ohtake T., Matsumoto A., Saito H., Ikuta K., Fujimoto Y., Ono M., Toyokuni S., Kohgo Y. Immunohistochemical detection of 4-hydroxy-2-hynonenal-modified-protein adducts in human alcoholic liver diseases. Alcohol Clin Exp Res. 22:1998;145-149.
12. Rolla R., Vay D., Mottaran E., Parodi M., Traverso N., Aric S., Sartori M., Bellomo G., Klassen L.W., Thiele G.M., Tuma D.J., Albano E. Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease. Hepatology. 31:2000;878-884.
13. Loguercio C., Del Vecchio Blanco C., Coltorti M., Nardi G. Alteration of erythrocyte glutathione synthetase in alcoholic and non-alcoholic cirrhosis. Scand J Clin Lab Invest. 52:1992;207-213.
14. Loguercio C., Clot P., Albano E., Argenzio F., Grella A., De Girolamo V., Delle Cave M., Del Vecchio Blanco C., Nardi G. Free radicals and not acetaldehyde influence the circulating levels of glutathione after acute or chronic alcohol abuse in vivo and in vitro studies. Ital J Gastroenterol Hepatol. 29:1997;168-173.
15. Loguercio C., Del Vecchio Blanco F., De Girolamo V., Disalvo D., Nardi G., Parente A., Del Vecchio Blanco C. Ethanol consumption, amino acids and glutathione blood levels in patients with and without chronic liver disease. Alcohol Clin Exp Res. 23:1999;1780-1784.
16. Mutlu-Turkoglu U., Ademoglu E., Turkoglu S., Badur S., Uysal M., Toker G. The effects of interferon-alpha on serum lipid peroxidation and total thiol content in patients with chronic active hepatitis-C. Res. Commun Mol Pathol Pharmacol. 96:1997;357-361.
17. Sumida Y., Nakashima T., Yoh T., Nakajima Y., Ishikawa H., Mitsuyoshi H., Sakamoto Y., Okanoue T., Kashima K., Nakamura H., Yodoi J. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol. 33:2000;616-622.
18. De Franceschi L., Fattovich G., Turrini F., Ayi K., Brugnara C., Manzato F., Noventa F., Stanzial A.M., Solero P., Corrocher R. Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection role of membrane oxidative damage. Hepatology. 31:2000;997-1004.
19. Vargiu C., Belliardo S., Cravanzola C., Grillo M.A., Colombatto S. Oxygen regulation of rat hepatocyte iNOS gene expression. J Hepatol. 32:2000;567-573.
20. Liu Z., Rudd M.A., Freedman J.E., Loscalzo J. S-transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther. 284:1998;526-536.
21. Van der Vliet A., Hoen P.A.C., Wong P.S.Y., Bast A., Cross C.E. Formation of S-nitrosothiols via direct nucleophilic nitrosation of thiols by peroxynitrite with elimination of hydrogen peroxide. J Biol Chem. 273:1998;30255-30262.
22. Ji Y., Akerboom T.P., Sies H., Thomas J.A. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitrosoglutathione. Arch Biochem Biophys. 362:1999;67-78.
23. Vos T.A., van Goor H., Tuyt L., de Jager-Krikken A., Leuvenink R., Kuipers F., Jansen P.L.M. Expression of inducible nitric oxide synthase in endotoxemic rat hepatocytes is dependent on the cellular glutathione status. Hepatology. 29:1999;421-426.
24. Fortenberry J.D., Owens M.L., Brown L.A. S-nitrosoglutathione enhances neutrophyl DNA fragmentation and cell death. Am J Physiol. 276:1999;435-442.
25. Carnovale C.E., Scapini C., Alvarez M., Favre C., Monti J., Carrillo M.C. Nitric oxide release and enhancement of lipid peroxidation in regenerating rat liver. J Hepatol. 32:2000;798-804.
26. Wang J.H., Redmond H.P., Di Wu Q., Bouchier-Hayes D. Nitric oxide mediates hepatocyte injury. Am J Physiol. 275:1998;1117-1126.
27. Mihm S., Fayyazi A., Ramadori G. Hepatic expression of inducible nitric oxide synthase transcripts in chronic hepatitis C virus infection relation to hepatic viral load and liver injury. Hepatology. 26:1997;451-458.
28. Majano P.L., Garca-Monzn C., Lpez-Cabrera M., Lara-Pezzi E., Fernndez-Ruiz E., Garca-Iglesias C., Borque M.J., Moreno-Otero R. Inducible nitric oxide synthase expression in chronic viral hepatitis. J Clin Invest. 101:1998;1343-1352.
29. Cuzzocrea S., Zingarelli B., Villari D., Caputi A.P., Longo G. Evidence for in vivo peroxynitrite production in human chronic hepatitis. Life Sci. 63:1998;25-30.
30. Loguercio C., Federico A., Tuccillo C., Disalvo D., Del Vecchio Blanco C. Increased nitric oxide production as evaluated by nitrosoglutathione levels in patients with chronic liver disease and alcohol abuse. (abstract) Gastroenterology. 118:2000;133.
31. Weyer S., Mihm S., Radzun H.J., Hartmann H., Fayyazi A. Liver infiltrating T lymphocytes express interferon γ and inducible nitric oxide synthase in chronic hepatitis C virus infection. Gut. 46:2000;255-259.
32. García-Monzón C., Majano P.L., Zubia I., Sanz P., Apolinario A., Moreno-Otero R. Intrahepatic accumulation of nitrotyrosine in chronic viral hepatitis is associated with histological severity of liver disease. J Hepatol. 32:2000;331-338.
33. Corrales F.J., Ruiz F., Mato J.M. In vivo regulation by glutathione of methionine adenosyltransferase S-nitrosylation in rat liver. J Hepatol. 31:1999;887-894.
34. Griffon B., Cillard J., Chevanne M., Morel I., Cillard P., Sergent O. Activated macrophages increase the susceptibility of rat hepatocytes to ethanol-induced oxidative stress conflicting effects of nitric oxide. Alcohol Alcohol. 35:2000;230-235.
35. Loguercio C., Di Pierro M. The role of glutathione in the gastrointestinal tract a review. Ital J Gastroenterol Hepatol. 31:1999;401-407.
36. Huang Z.Z., Li H., Cai J., Kuhlenkamp J., Kaplowitz N., Lu S.C. Changes in glutathione homeostasis during liver regeneration in the rat. Hepatology. 27:1998;147-153.
37. Nishikawa M., Sato E.F., Kashiba M., Kuroki T., Utsumi K., Inoue M. Role of glutathione in nitric oxide-dependent regulation of energy metabolism in rat hepatoma cells. Hepatology. 26:1998;422-426.
38. Voehringer D.W., McConkey D.J., McDonnel T.J., Brisbay S., Meyn R.E. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. USA. 95:1998;2956-2960.
39. Hall A.G. Glutathione and the regulation of cell death. Adv Exp Med Biol. 457:1999;199-203.
40. Loguercio C., Nardi G., Argenzio F., Aurilio C., Petrone E., Grella A., Del Vecchio Blanco C., Coltorti M. Effect of S-adenosyl-methionine administration on red blood cell cysteine and glutathione levels in alcoholic in patients with or without liver disease. Alcohol Alcohol. 29:1994;597-604.
41. Loguercio C., Piscopo P., Guerriero C., De Girolamo V., Disalvo D., Del Vecchio Blanco C. Effect of alcohol abuse and glutathione administration on the circulating levels of glutathione and on antipyrine metabolism in patients with alcoholic liver cirrhosis. Scand J Clin Lab Invest. 56:1996;441-447.
42. Lieber C.S. Alcohol and the liver metabolism of alcohol and its role in hepatic and extrahepatic diseases. Mt Sinai J Med. 67:2000;84-94.
43. Swietek K., Juszczyk J. Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J Viral Hepat. 4:1997;139-141.
44. Barbaro G., Di Lorenzo G., Ribersani M., Soldini M., Giancaspro G., Bellomo G., Belloni G., Grisorio B., Barbarini G. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype. J Hepatol. 30:1999;774-782.
45. Bailey S.M., Patel V.B., Young T.A., Asayama K., Cunningham C.C. Chronic ethanol consumption alters the glutathione/glutathione peroxidase-1 system and protein oxidation status in rat liver. Alcohol Clin Exp Res. 25:2001;726-733.
46. Swart P.J., Hirano T., Kuipers M.E., Ito Y., Smit C., Hashida M., Nishikawa M., Beljiaars L., Meijer D.K., Poelstra K. Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic livers. J Hepatol. 31:1999;1034-1043.
47. Koch O., Farre S., De Leo M.E., Palozza P., Palazzotti B., Borrelo S., Palombini G., Cravero A., Galeotti T. Regulation of manganese superoxide dismutase (MnSOD) in chronic experimental alcoholism effects of vitamin E -supplemented and -deficient diets. Alcohol Alcohol. 35:2000;159-163.
48. Newsome P.M., Beldon I., Moussa Y., Delahooke T.E., Poulopoulos G., Hayes P.C., Plevris J.N. Low serum retinol levels are associated with hepatocellular carcinoma in patients with chronic liver disease. Aliment Pharmacol Ther. 14:2000;1295-1301.
49. Shen H., Yang C., Liu J., Ong C. Dual role of glutathione in selenite-induced oxidative stress and apoptosis in human hepatoma cells. Free Radic Biol Med. 28:2000;1115-1124.
50. Sakaguchi S., Iizuka Y., Furusawa S., Tanaka Y., Takayanagi M., Takayanagi Y. Role of selenium in endotoxin-induced lipid peroxidation in the rats liver and in nitric oxide production in J774A.1 cells. Toxicol Lett. 118:2000;677-699.
51. Atkinson J.B., Hill K.E., Burk R.F. Centrilobular endothelial cell injury by diquat in the selenium-deficient rat liver. Lab Invest. 81:2001;193-200.
52. Liu S., Shia D., Liu G., Chen H., Liu S., Hu Y. Roles of Se and NO in apoptosis of hepatoma cells. Life Sci. 68:2000;603-610.
53. Fisher A., Pallauf J., Gohil K., Weber S.U., Packer L., Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem Biophys Res Commun. 285:2001;470-475.
54. Loguercio C., De Girolamo V., Federico A., Feng S.L., Cataldi V., Del Vecchio Blanco C., Gialanella G. Trace elements and chronic liver diseases. J Trace Elem Med Biol. 11:1997;158-161.
55. Loguercio C., De Girolamo V., Federico A., Feng S.L., Crafa E., Cataldi V., Gialanella G., Moro R., Del Vecchio Blanco C. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Bio. Trace Elem Res. 81:2001;245-254.
56. Hayes P.C., Bouchier J.A.D., Beckett G.J. Glutathione S-transferase in humans in heath and disease. Gut. 32:1991;813-818.
57. Vanhaecke T., Lindros K.O., Oinonen T., Vercruysse A., Rogiers V. Effect of long-term ethanol exposure on the acinar distribution of hepatic glutathione-S-transferase. Drug Metab Dispos. 28:2000;1470-1474.
58. Giannini E., Risso D., Ceppa P., Botta F., Chiarbonello B., Fasoli A., Malfatti F., Romagnoli P., Lantieri P.B., Testa R. Utility of alpha-glutathione S-transferase assessment in chronic hepatitis C patients with near normal alanine aminotransferase levels. Clin Biochem. 33:2000;297-301.
59. Loguercio C., De Girolamo V., Cuomo A., Argenzio F., Iannotta C., Disalvo D., Grella A., Del Vecchio Blanco C. Determination of plasma alpha-glutathione-S-transferases in chronic alcohol abusers relationship with alcohol intake and liver involvement. Alcohol Alcohol. 33:1998;366-372.
60. Loguercio C., Tuccillo C., Caporaso N., Del Vecchio Blanco G., Morisco F., Guerriero C., di Santolo S.S., Valenza L.M., Del Vecchio Blanco C. Determination of plasma alpha-glutathione S-transferases in patients with HCV-related chronic infection its significance and possible clinical relevance. Liver. 18:1998;166-172.
61. Loguercio C., Caporaso N., Tuccillo C., Morisco F., Del Vecchio Blanco G., Del Vecchio Blanco C. Alpha-glutathione transferases in HCV-related chronic hepatitis a new predictive index of response to interferon therapy? J Hepatol. 28:1998;390-395.
62. Herrera B., Alvarez A.M., Sanchez A., Fernandez M., Roncero C., Benito M., Fabregat I. Reactive oxygen species (ROS) mediates the mitochondrial-dependent apoptosis induced by transforming growth factor (beta) in fetal hepatocytes. FASEB J. 15:2001;741-751.
63. Herrera B., Fernandez M., Alvarez A.M., Roncero C., Benito M., Gil J., Fabregat I. Activation of caspases occurs downstream from radical oxygen species production, Bcl-xL down-regulation, and early cytochrome C release in apoptosis induced by transforming growth-factor β in rat fetal hepatocytes. Hepatology. 34:2001;548-556.
64. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776.
65. Clavien P.A., Rudiger H.A., Selzner M. Mechanisms of hepatocyte death after ischemia apoptosis versus necrosis. Hepatology. 33:2001;1555-1557.
66. Jaeschke H., Ho Y.S., Fisher M.A., Lawson J.A., Farhood A. Glutathione peroxidase-deficient mice are more susceptible to neutrophyl-mediated hepatic parenchymal cell injury during endotoxemia importance of an intracellular oxidant stress. Hepatology. 29:1999;443-450.
67. Muschen M., Warskulat U., Peters-Regehr T., Bode J.G. Kubitz, R.; Haussinger, D. Involvement of CD95 (apo-1/Fas) ligand expressed by rat kupffer cells in hepatic immunoregulation. Gastroenterology. 116:1999;666-677.
68. Rashid A., Wu T.-C., Huang C.-C., Chen C.-H., Lin H.Z., Yang S.Q., Lee Fung Y.J., Diehl A.M. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology. 29:1999;1131-1138.
69. Niemel O., Parkkila S., Juvonen R.O., Viitala K., Gelboin H.V., Pasanen M. Cytochromes P450 2A6, 2E1, and 3A and production of protein-aldehyde adducts in the liver of patients with alcoholic and non-alcoholic liver diseases. J Hepatol. 33:2000;893-901.
70. Selzner M., Rdiger H.A., Sindram D., Madden J., Clavien P.-A. Mechanism of ischemic injury are different in steatotic and normal rat liver. Hepatology. 32:2000;1280-1288.
71. Loguercio C., De Girolamo V., de Sio I., Tuccillo C., Ascione A., Baldi F., Budillon G., Cimino L., Di Carlo A., Di Marino M.P., Morisco F., Picciotto F., Terracciano L., Vecchione R., Verde V., Del Vecchio Blanco C. Non-alcoholic fatty liver disease in an area of southern Italy main clinical, histological, and pathophysiological aspects. J Hepatol. 35:2001;568-574.
72. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med. 22:1997;287-305.
73. Bonis P.A., Friedman S.L., Kaplan M.M. Is liver fibrosis reversible? N Engl J Med. 344:2001;452-454.
74. Parola M., Robino G. Oxidative stress-related molecules and liver fibrosis. J Hepatol. 35:2001;297-306.
75. Mendoza L., Carrascal T., De Luca M., Fuentes A.M., Salado C., Blanco J., Vidal-Vanaclocha F. Hydrogen peroxide mediates vascular cell adhesion molecule-1 expression from interleukin-18-activated hepatic sinusoidal endothelium implications for circulating cancer cell arrest in the murine liver. Hepatology. 34:2001;298-310.
76. Rizzetto, M.; Purcell, R. H.; Gerin, J. L.; Verme, G., eds. Viral Hepatitis and Liver Disease. Turin: Minerva Medica; 1997.
77. Bloomer, J. R.; Goodman, Z. D.; Ishak, K. G., eds. Clinical and pathological correlations in liver disease: approaching the next millennium. Washington: Academica Press Inc.; 1998.
78. Dudnik L.B., Viksna L.M., Maiore A.I. Lipid peroxidation and its connection with the change in composition and antioxidant properties of lipids in comatogenic forms of acute viral hepatitis B. Vopr Med Khim. 46:2000;597-609.
79. Lok Suk-Fong A. Hepatitis B infection pathogenesis and management. J Hepatol. 32:2000;89-97.
80. Zima T., Fialova L., Mestek O., Janebova M., Crkovska J., Malbohan I., Stipek S., Mikulikova L., Popov P. Oxidative stress, metabolism of ethanol and alcohol-related diseases. J Biomed Sci. 8:2001;59-70.
81. Tilg H., Diehl A.M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 343:2000;1467-1476.
82. Higuchi H., Adachi M., Miura S., Gores G.J., Ishii H. The mitochondrial permeability transition contributes to acute ethanol-induced apoptosis in rat hepatocytes. Hepatology. 34:2001;320-328.
83. Brown L.A., Harris F.L., Guidot D.M. Chronic ethanol ingestion potentiates TNF-alpha-mediated oxidative stress and apoptosis in rat type II cells. Am J Physiol Lung Cell Mol Physiol. 281:2001;377-386.
84. Kono H., Uesugi T., Froh M., Rusyn I., Bradford B.U., Thurman R.G. ICAM-1 is involved in the mechanism of alcohol-induced liver injury studies with knockout mice. Am J Physiol Gastrointest Liver Physiol. 280:2001;G1289-G1295.
85. Natori S., Rust C., Stadheim L.M., Srinivasan A., Burgart L.J., Gores G.J. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J Hepatol. 34:2001;248-253.
86. Ziol M., Tepper M., Lohez M., Arcangeli G., Ganne N., Christidis C., Trinchet J.C., Beaugrand M., Guillet J.G., Guettier C. Clinical and biological relevance of hepatocyte apoptosis in alcoholic hepatitis. J Hepatol. 34:2001;330-333.
87. Uchimura K., Nakamuta M., Enjoji M., Irie T., Sugimoto R., Muta T., Iwamoto H., Nawata H. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kupffer cells. Hepatology. 33:2001;91-99.
88. Chen J., Robinson N.C., Schenker S., Frosto T.A., Henderson G.I. Formation of 4-hydroxynonenal adducts with cytochrome c oxidase in rats following short-term ethanol intake. Hepatology. 29:1999;1792-1798.
89. Dupont I., Bodenez P., Berthou F., Simon B., Bardou L.G., Lucas D. Cytochrome P-450 2E1 activity and oxidative stress in alcoholic patients. Alcohol Alcohol. 35:2000;98-103.
90. Ostapowikz G., Watson K.J.R., Locarnini S.A., Desmond P.V. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection. Hepatology. 27:1998;1730-1735.
91. Loguercio C., Di Pierro M., Di Marino M.P., Federico A., Disalvo D., Crafa E., Tuccillo C., Baldi F., Del Vecchio Blanco C. Drinking habits of subjects with hepatitis C virus-related chronic liver disease prevalence and effect on clinical, virological and pathological aspects. Alcohol Alcohol. 35:2000;296-301.
92. Niemela O., Parkkila S., Pasanen M., Viitala K., Villanueva J.A., Halsted C.H. Induction of cytochrome P450 enzymes and generation of protein-aldehyde adducts are associated with sex-dependent sensitivity to alcohol-induced liver disease in micropigs. Hepatology. 30:1999;1111-1117.
93. Rice C.M. Sex and hepatic fibrosis. Hepatology. 29:1999;990-991.
94. Kono H., Wheeler M.D., Rusyn I., Lin M., Seabra V., Rivera C.A., Bradford B.U., Forman D.T., Thurman R.G. Gender differences in early alcohol-induced liver injury role of CD14, NF-kB, and TNF-α Am J Physiol Gastrointest Liver Physiol. 278:2000;652-661.
95. Yin M., Ikejima K., Wheeler M.D., Bradford B.U., Vitor S., Forman D.T., Sato N., Thurman R.G. Estrogen is involved in early alcohol-induced liver injury in a rat enteral feeding model. Hepatology. 31:2000;117-123.
96. Jrvelinen H.A., Orpana A., Perola M., Savolainen V.T., Karhunen P.J., Lindros K.O. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology. 33:2001;1148-1153.
97. Guebre-Xabier M., Yang S., Lin H.Z., Schwenk R., Krzych U., Diehl A.M. Altered hepatic lymphocyte subpopulations in obesity-related murine fatty livers potential mechanism for sensitization to liver damage. Hepatology. 31:2000;633-640.
98. Baraona E., Abittan C.S., Dohmen K., Moretti M., Pozzato G., Chayes Z.W., Schaefer C., Lieber C.S. Gender differences in pharmacokinetics of alcohol. Alcohol Clin Exp Res. 25:2001;502-507.
99. Kern P.A., Ranganathan S., Li C., Wood L., Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 280:2001;745-751.
100. Cahill A., Stabley G.J., Wang X., Hoek J.B. Chronic ethanol consumption causes alterations in the structural integrity of mitochondrial DNA in aged rats. Hepatology. 30:1999;881-888.
101. Aruoma O.I. Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol. 32:1994;671-683.
102. Tsukada H., Wang P.-Y., Kaneko T., Wang Y., Nakano M., Sato A. Dietary carbohydrate intake plays an important role in preventing alcoholic fatty liver in the rat. J Hepatol. 29:1998;715-724.
103. Pawlosky R.J., Flynn B.M., Salem N. The effects of low dietary levels of polyunsaturates on alcohol-induced liver disease in Rhesus monkeys. Hepatology. 26:1997;1386-1392.
104. Nanji A.A., Zakim D., Rahemtulla A., Daly T., Miao L., Zhao S., Khwaja S., Tahan S.R., Dannenberg A.J. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology. 26:1997;1538-1545.
105. Polavarapu R., Spitz D.R., Sim J.E., Follansbee M.H., Oberley L.W., Rahemtulla A., Nanji A.A. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets hog in corn oil and fish oil. Hepatology. 27:1998;1317-1323.
106. Lu S.C., Huang Z.-Z., Yang J.M., Tsukamoto H. Effect of ethanol and high-fat feeding on hepatic γ-glutamylcysteine synthetase subunit expression in the rat. Hepatology. 30:1999;209-214.
107. Yu M.-W., Hsieh H.-H., Pan W.-H., Yang C.-S., Chen C.-J. Vegetable consumption, serum retinol level, and risk of hepatocellular carcinoma. Cancer Res. 55:1995;1301-1305.
108. Rocchi E., Seium Y., Camellini L., Casalgrandi G., Borghi A., D'Alimonte P., Cioni G. Hepatic tocopherol content in primary hepatocellular carcinoma and liver metastases. Hepatology. 26:1997;67-72.
109. Loguercio C., Cuomo A., Gazzerro P., Cioffi M., Molinari A.M., Del Vecchio Blanco C. P53 expression in liver samples of patients with HCV-related chronic hepatitis. (abstract) Hepatology. 28:1998;1752.
110. Lieber C.S. Alcoholic liver disease new insights in pathogenesis lead to new treatments. J Hepatol. 32:2000;113-128.
111. Bellezzo J.M., Leingang K.A., Bulla G.A., Britton R.S., Bacon B.R., Fox E.S. Modulation of lipopolysaccharide-mediated activation in rat kupffer cells by antioxidant. J Lab Clin Med. 131:1998;36-44.
112. Hu J.-F., Cheng Z., Chisari F.V., Vu T.H., Hoffman A.R., Campbell T.C. Repression of hepatitis B virus (HBV) transgene and HBV-induced liver injury by low protein diet. Oncogene. 15:1997;2795-2801.
113. Chojkier M., Houglum K., Lee K.S., Buck M. Long- and short-term D-α-tocopherol supplementation inhibits liver collagen α1(I) gene expression. Am J Physiol. 275:1998;1480-1485.
114. Godichaud S., Krisa S., Couronn B., Dubuisson L., Mrillon J.M., Desmoulire A., Rosenbaum J. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology. 31:2000;922-931.
115. Bleich S., Degner D. Reversal of ethanol-induced hepatic steatosis and lipid peroxidation by taurine a study in rats. Alcohol Alcohol. 35:2000;215-219.
116. Ben-Shaul V., Lomnitski L., Nyska A., Carbonatto M., Peano S., Zurovsky Y., Bergman M., Eldridge S.R., Grossman S. Effect of natural antioxidant and apocynin on LPS-induced endotoxemia in rabbit. Hum Exp Toxicol. 19:2000;604-614.
117. Soltys K., Dikdan G., Koneru P. Oxidative stress in fatty livers of obese Zucker rats rapid amelioration and improved tolerance to warm ischemia with tocopherol. Hepatology. 34:2001;13-18.
118. Turkodgan M.K., Agaoglu Z., Yener Z., Sekeroglu R., Akkan H.A., Avci M.E. The role of antioxidant vitamins (C and E), selenium and nigella sativa in the prevention of liver fibrosis and cirrhosis in rabbits new hopes. Dtsch Tierarztl Wochenschr. 108:2001;71-73.
119. Kono H., Arteel G.E., Rusyn I. Sies, H.; Thurman, R. G. Ebselen prevents early alcohol-induced liver injury in rats. Free Radic Biol Med. 30:2001;403-411.
120. Flora K., Hahn M., Rosen H., Benner K. Milk thistle (Silybum marianum) for the therapy of liver disease. Am J Gastroenterol. 93:1998;139-143.
121. Wasser S., Sian Ho J.M., Khengm A.H., Eng Looi T.C. Salvia miltiorrhiza reduces experimentally-induced hepatic fibrosis in rats. J Hepatol. 29:1998;760-771.
122. Ott M., Thyagarajan P., Gupta S. Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors. Eur J Clin Invest. 27:1997;908-915.
123. Kaiano K., Sakaida I., Uchida K., Okita K. Inibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. J Hepatol. 29:1998;642-649.
124. Shuppan D., Ji-Dong J., Brinkhaus B., Hahn E.G. Herbal products for liver diseases a therapeutic challenge for the new millenium. Hepatology. 30:1999;1099-1104.
125. Von Herbay A., Stahl W., Niederau C., Sies H. Vitamin E improves the aminotransferase status of patients suffering from viral hepatitis C a randomized, double-blind, placebo-controlled study. Free Radic Res. 27:1997;599-605.
126. Houglum K., Venkataramani A., Lyche K., Chojkier M. A pilot study of the effects of d-α-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology. 113:1997;1069-1073.
127. Mato J.M., Cmara J., Fernndez de Paz J., Caballeria L., Coll S., Caballero A., Garcia-Buey L., Beltrn J., Benita V., Caballeria J., Sol R., Moreno-Otero R., Barrao F., Martin-Duce A., Correa J.A., Pars A., Barrao E., Garcia-Magaz I., Puerta J.L., Moreno J., Boissard G., Ortiz P., Rods J. S-adenosylmethionine in alcoholic liver cirrhosis a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 30:1999;1081-1089.
128. Pars A., Planas R., Torres M., Caballeria J., Viver J.M., Acero D., Pans J., Rigau J. Santos. J.; Rods, J. Effects of silymarin in alcoholic patients with cirrhosis of the liver results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 28:1998;615-621.
129. Mitsuyoshi H., Nakashima T., Sumida Y., Yoh T., Nakajima Y., Iscikawa H., Inaba K., Sakamoto Y., Okanoue T., Kashima K. Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants. Biochem Biophys Res Commun. 263:1999;537-542.
130. Fiorucci S., Santucci L., Antonelli E., Distrutti E., Del Sero G., Morelli O., Romani L., Federici B., Del Soldato P., Morelli A. NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokines. Gastroenterology. 118:2000;404-421.
131. Kuo P.C., Abe K., Schroeder R.A. Superoxide enhances interleukin 1β-mediated transcription of the hepatocyte-inducible nitric oxide synthase gene. Gastroenterology. 118:2000;608-618.
132. Shah V., Chen A.F., Cao S., Hendrickson H., Weiler D., Smith L., Yao J., Katusic Z.S. Gene transfer of recombinant endothelial nitric oxide synthase to liver in vivo and in vitro. Am J Physiol Gastrointest Liver Physiol. 279:2000;G1023-G1030.
133. Wheeler M.D., Kono H., Yin M., Rusyn I., Froh M., Connor H.D., Mason R.P., Samulski R.J., Thurman R.G. Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcohol-induced liver injury in rats. Gastroenterology. 120:2001;1241-1250.
134. Swart P.J., Hirano T., Kuipers M.E., Ito Y., Smit C., Hashida M., Nishikawa M., Beljaars L., Meijer D.K.F., Poelstra K. Targeting of superoxide dismutase to the liver results in anti-inflammatory effects in rats with fibrotic livers. J Hepatol. 31:1999;1034-1043.
135. Wheeler M.D., Kono H., Rusyn I., Arteel G.E., McCarty D., Samulski R.J., Thurman R.G. Chronic ethanol increases adeno-associated viral transgene expression in rat liver via oxidant and NFkB-dependent mechanisms. Hepatology. 32:2000;1050-1059.
136. Naveau S. Acute alcoholic hepatitis treatments. Presse Med. 30:2001;1024-1030.
137. Yee L.J., Tang J., Gibson A.W., Kimberly R., Van Leeuwen D.J., Kaslow R.A. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology. 33:2001;708-712.
138. Nelson D.R., Lauwers G.Y., Lau J.Y., Davis G.L. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C a pilot trial of interferon nonresponders. Gastroenterology. 118:2000;655-660.
139. Mari M., Cederbaum A.I. Induction of catalase, alpha, and microsomal glutathione S-transferase in CYP2E1 overexpressing HepG2 cells and protection against short-term oxidative stress. Hepatology. 33:2001;652-661.